Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151

Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397

Intraepithelial CD8 + tumor-infiltrating lymphocytes and a high CD8 + /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

Sato, E., Olson, S. H., Ahn, J., Bundy, B. N., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C. B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,445

The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies

Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022

Immunosuppressive Strategies that are Mediated by Tumor Cells

Rabinovich, G. A., Gabrilovich, D. I., & Sotomayor, E. M. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,747

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

Davé, S. S., Wright, G. W., Tan, B. K., Rosenwald, A., Gascoyne, R. D., Chan, W. C., Fisher, R. I., Braziel, R. M., Rimsza, L. M., Grogan, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041869 · Cited by 1,417

Chapter 2: The burden of HPV-related cancers

Parkin, D. M., & Bray, F. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.111 · Cited by 1,391

Roles of the NKG2D immunoreceptor and its ligands

Raulet, D. H. (2003) · Nature reviews. Immunology · doi:10.1038/nri1199 · Cited by 1,351

The natural history of cervical HPV infection: unresolved issues

Woodman, C. B. J., Collins, S. I., & Young, L. S. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2050 · Cited by 1,056

Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma

Hiraoka, K., Miyamoto, M., Cho, Y., Suzuoki, M., Oshikiri, T., Nakakubo, Y., Itoh, T., Ohbuchi, T., Kondo, S., & Katoh, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602934 · Cited by 480

Immune cell densities, HLA status, and PD-L1 expression in stage I neuroendocrine neoplasm of the uterine cervix

Yamada, R., Kawakami, F., Maeda, N., Nagao, S., Yamamoto, M., Motohara, T., Kondoh, E., Mikami, Y., & Komohara, Y. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156146 · Cited by 2

The spontaneous neoantigen-specific CD4 + T-cell response to a growing tumor is functionally and phenotypically diverse

Griswold, R. Q., Brightman, S. E., Zavala, K. S., Ordaz-Arias, M. A., Djassemi, N., Thota, R. R., Naradikian, M. S., Dose, H., Alarcón, S., Vijayanand, P., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012209 · Cited by 1

Tumor Infiltration by Immune Cells: Pathologic Evaluation and a Clinical Significance

Gutkin, D. W. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_3 · Cited by 1

Screening and Identification of New Biomarkers for the Control of Cervical CancerPreprint

Uyeda, M., & Subramanian, M. (2020) · Preprints.org · doi:10.20944/preprints202010.0220.v1 · Cited by 2

Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation

MacDuffie, E., Cocka, L., Lin, X., Bvochora-Nsingo, M. F., Chiyapo, S., Balang, D., Maswabi, B. C. L., Ngoni, K., Ramogola‐Masire, D., Zetola, N. M., et al. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0364 · Cited by 1

Comprehensive Immunomonitoring to Guide the Development of Immunotherapeutic Products for Cancer

Welters, M. J. P., & van der Burg, S. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00016-6 · Cited by 1

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Punt, S., de Jong, R. J. B., & Jordanova, E. S. (2017) · Journal of Visualized Experiments · doi:10.3791/55589 · Cited by 1

Major Histocompatibility Complex Class I-related Chain A and B Gene Expression in Sepsis Patient

Yıldız, Ş. M., Atli, G., Güleç, E., Güvenç, B., & Özcengiz, D. (2017) · International Journal of Human Genetics · doi:10.1080/09723757.2017.1305724 · Cited by 1

New biomarkers for antenatal infection: MICA and MICB gene expression in preterm babies

Özlü, F., Akçalı, M., Yıldız, Ş. M., Yıldızdaş, H. Y., Gözet, Y., & Atay, A. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1387528 · Cited by 1

Immunotherapy for Precancerous Lesions of the Uterine Cervix

Farghaly, S. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-02701-8_7 · Cited by 1

Immunotherapy of gastrointestinal stromal tumors: current view and future directions

Boichuk, S., Abduraeva, S. A., & Kopnin, P. (2023) · Advances in molecular oncology · doi:10.17650/2313-805x-2023-10-2-17-29 · Cited by 1

Design and delivery strategies of alphavirus replicon-based cervical cancer vaccines

van de Wall, M.-N. S. (2018) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1

Caracterização do genoma e da resposta imune no microambiente tumoral de neoplasias PTEN-deficientes

Vidotto, T. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-29072019-142549 · Cited by 1

Potential Biomarkers for Cervical Cancer Screening and TreatmentPreprint

Uyeda, M., & Subramanian, M. (2020) · Preprints.org · doi:10.20944/preprints202010.0220.v2 · Cited by 1

Avaliação imunológica da vacina proteica E6E7 fusionada a Ubiquitina contra cancer cervical induzido por HPV16.

de Oliveira, L. M. F. (2012) · doi:10.11606/d.87.2012.tde-05022013-093824

Characterisation of anti-glycan monoclonal antibodies

Noble, P. W. (2011) · Nottingham ePrints (University of Nottingham)

Epigenetic quantification of tumor-infiltrating T-lymphocytes in epithelial ovarian tumors

Vasconcelos, I. I. M. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6760

Tumor-mediated changes in the immune system of cancer patients - a balancing act between suppressors and effectors

Poschke, I. C. (2011) · Figshare

Studies on the influence of human papillomaviruses (HPV) and other biomarkers on the prevalence of oropharyngeal cancer and clinical outcome

Näsman, A. (2013) · Figshare

Methodological Approaches towards Personalised Cancer Medicine

Mints, M. (2015) · Figshare

Managing Regulatory T Cells to Improve Cancer Immunotherapy

Curiel, T. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4732-0_9

Mechanisms of CD4+ Regulatory T Cell Heterogeneity in Health and Disease

Grant, F. M. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.46516

Immunogenomic Intertumor Heterogeneity Across Primary and Metastatic Sites in a Patient With Lung AdenocarcinomaPreprint

Chen, R., Li, J., Fujimoto, J., Hu, X., Quek, K., Tang, M., Mitra, A., Behrens, C., Chow, C.-W. B., Jiang, P., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-970663/v1

Development of Antitumor Cellular Immunity

Welters, M. J. P., & van der Burg, S. H. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_5

Tumor immunology and the application of immunotherapy in ovarian carcinoma

Paijens, S. T. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.182133606

The Relationship between Area of Necrosis with Degree of Lymphocytes Infiltration in Breast Rattus norvegicus Induced by DMBA

Fairus, A., Hajiri, A. Z. Z. A., Ulya, H., Farid, S., Veterini, L., & Nasir, M. (2022) · SRIWIJAYA JOURNAL OF MEDICINE · doi:10.32539/sjm.v5i1.126

Additional file 2 of Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma

Chen, R., Li, J., Fujimoto, J., Hong, L., Hu, X. Y., Quek, K., Tang, M., Mitra, A., Behrens, C., Chow, C.-W. B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19753371

A Systemic Review of T Regulatory Cells and Their Role In Hodgkin and Non-Hodgkin Lymphoma

Taur, N., Kushwah, R., Jain, M., Singh, A., & Mittal, R. (2024) · Annals of Pathology and Laboratory Medicine · doi:10.21276/apalm.3258

Additional file 1 of Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma

Chen, R., Li, J., Fujimoto, J., Hong, L., Hu, X., Quek, K., Tang, M., Mitra, A., Behrens, C., Chow, C.-W., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19753368

Tumor Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma—A Systematic Review

Loo, L. Y., Tay, S. H., & Oh, C. (2026) · Dermatopathology · doi:10.3390/dermatopathology13010006

Aspects fonctionnels et pronostiques des cellules myéloïdes suppressives et de Foxp3 dans le cancer

Ladoire, S. (2011) · theses.fr (ABES) · doi:10.70675/f95be627zd09cz4fd2za49fz6b11ffb7363d

Role and prognostic importance of regulatory T cells in lung cancer patients, according to the presence of tertiary lymphoid structures

Devi-Marulkar, P. (2015) · theses.fr (ABES) · doi:10.70675/1afef94czc6daz4936zb0d3z44f75d1762b1

Comparative Analysis of Immune Cell-Type Abundances in Periprosthetic Tissues Across Arthroplasty Failure Etiologies

Li, Y., Wang, F., YICHANG, L., Mu, W., Ji, B., Zhang, X., & Cao, L. (2026) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.25.01505

Immunoguiding, the Final Frontier in the Immunotherapy of Cancer

van der Burg, S. H., Walter, S., Janetzki, S., Britten, C. M., Galon, J., Welters, M. J. P., & Gouttefangeas, C. (2014) · Springer eBooks · doi:10.1007/978-3-319-05104-8_5

A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix

Shah, W., Yan, X., Li, J., Zhou, Y., Chen, H., & Wang, Y. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.56 · Cited by 266

Intraepithelial CD8 + tumor-infiltrating lymphocytes and a high CD8 + /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

Sato, E., Olson, S. H., Ahn, J., Bundy, B. N., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C. B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,445

Tumor‐infiltrating CD14‐positive myeloid cells and CD8‐positive T‐cells prolong survival in patients with cervical carcinoma

van Steenwijk, P. J. D. V., Ramwadhdoebé, T. H., Goedemans, R., Doorduijn, E. M., van Ham, J. J., Gorter, A., van Hall, T., Kuijjer, M. L., van Poelgeest, M. I. E., van der Burg, S. H., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28309 · Cited by 130

Downregulation of HLA Class I Expression through HLA-A DNA Methylation Is Associated with Reduced CD8+ T-cell Infiltration in Cervical Cancer

Yoshimoto, D., Iuchi, H., Taguchi, A., Sone, K., Tamai, K., Mori, A., Kitamura, S., Duong, A. Q., Ishizaka, A., Kusakabe, M., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-0594 · Cited by 3

Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy

Ohno, A., Iwata, T., Katoh, Y., Taniguchi, S., Tanaka, K., Nishio, H., Nakamura, M., Morisada, T., Chen, G., Saito, M., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.07.106 · Cited by 51